AdaptHealth Q2 2024 Adj EPS $0.13 Misses $0.16 Estimate, Sales $806.00M Beat $802.63M Estimate
Portfolio Pulse from Benzinga Newsdesk
AdaptHealth (NASDAQ:AHCO) reported Q2 2024 earnings per share of $0.13, missing the analyst estimate of $0.16 by 18.75%. However, the company reported sales of $806.00 million, beating the estimate of $802.63 million by 0.42%. This represents a 1.60% increase over the same period last year.
August 06, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AdaptHealth reported Q2 2024 EPS of $0.13, missing the $0.16 estimate by 18.75%, but sales of $806M beat the $802.63M estimate by 0.42%, up 1.60% YoY.
The mixed results, with EPS missing estimates but sales beating expectations, suggest a neutral short-term impact on AHCO's stock price. Investors may weigh the earnings miss against the sales beat and YoY growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100